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The design of erodible biomaterials relies on the ability to program the in vivo retention
time, which necessitates real-time monitoring of erosion. However, in vivo performance
cannot always be predicted by traditional determination of in vitro erosion1,2, and standard
methods sacrifice samples or animals3, preventing sequential measures of the same
specimen. We harnessed non-invasive fluorescence imaging to sequentially follow in vivo
material-mass loss in order to model the degradation of materials hydrolytically
(PEG:dextran hydrogel) and enzymatically (collagen). Hydrogel erosion rates in vivo and in
vitro correlated, enabling the prediction of in vivo erosion of new material formulations from
in vitro data. Collagen in vivo erosion was used to infer physiologic in vitro conditions that
mimic erosive in vivo environments. This approach enables rapid in vitro screening of
materials, and can be extended to simultaneously determine drug release and material
erosion from a drug-eluting scaffold, or cell viability and material fate in tissue-engineering
formulations.
Biodegradable materials serve as platforms for structural stabilization, void filling, drug
delivery and tissue engineering 4–8 offering the promise of reduced complications posed by
permanent foreign objects.9 Yet, controlled material development is limited as degradation
in vivo is more complex than in vitro, and in vitro assays are rarely adequate measures of
implant behavior. Loss of material integrity, structure, and eventually mass progress
dependently over time but are dominated by different environmental forces in vitro and in
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vivo. The question remains as to whether erosion or loss of mass in one domain can predict
performance in the other. Gravimetric determinations from periodic sampling of explant
weight cannot follow the same formulation over time, necessitate large number of animals to
follow small number of samples and have excessive variability.3,10,11,12,13. Chromatography
tracks molecular weight changes 2,12 but cannot be applied to eliminable materials that do
not undergo chain scission. Material environment affects erosion, and the material and
degradation products may affect the environment in turn14,15. Thus, in vivo residence times
and in vitro durability of three dimensional degradable structures differ2.
We developed a noninvasive imaging technique that tracks material erosion in vivo through
a fluorescent tag covalently attached to components of model materials. Materials erosion
was calculated from the decay in total material fluorescence signal using non-invasive In
Vivo Imaging System (IVIS). Model hydrolytically degradable adhesive materials used
herein are based on polyethylene glycol (PEG) amine and dextran aldehyde16,17. PEG
replete with amine groups and oxidized dextran react at body temperature in a Schiff base
reaction to form adhesive materials as aldehydes bind to tissue amines. The reaction is
reversible and the material hydrolyzes to its polymeric components16,17. Although PEG
polymers may undergo enzymatic degradation, significant fluid uptake and swelling
dominate the degradation of our formulated PEG:dextran hydrogels, resulting in hydrolytic-
sensitive materials. As material shape dictates fluid uptake, we examined whether
fluorescence tracking could distinguish the fate of PEG:dextran formulations cast in a series
of shapes, sizes and varied PEG solid content. Compressed denatured type II collagen was
used as a model for enzymatically degradable material whose erosion profile should change
with implantation site and natural variation in enzyme content.
To enable the use of tagged materials to measure erosion rate, we verified that fluorescent
tagging had no effect on material properties. Indeed, swelling and erosion kinetics
(Supplementary Figure 1a), gelation time (Supplementary Figure 1b) and adhesion to
biological tissues (Supplementary Figure 1c) of PEG:dextran were unaffected by 5%
fluorescent PEG (demonstrated using the following formulation of dextran, D10-50-14 and
PEG, P8-10-40, as described in Supplementary Table 2). Fluorescent tag tracking however
provides different erosion kinetics than conventional wet gravimetric analysis. The two
assays demonstrated identical duration of material integrity. Yet, while tag-tracking
indicated immediate erosion upon immersion, gravimetric determinations inferred material
weight gain until swelling peaked (supplementary Figure 2). Indeed, erosion determined by
gravimetric analysis was 40% faster than by fluorescent tracking, as the former likely
considers elution of media trapped within the network during swelling and not just erosion
of polymeric chains. When the effect of swelling is eliminated and gravimetric analysis was
performed after samples were dried, the erosion profile coincided with the fluorescent
profile (supplementary Figure 2), up to the limit of scale sensitivity in the regime where
fluorescent quantification remains constantly sensitive. Such drying removes samples from
further experimentation and is inappropriate for in vivo implants. Fluorescent tracking
allows high fidelity identification of polymeric chains released from the bulk gel
sequentially from the onset of immersion and without sample destruction.
Hydrophilic material swelling and dissolution is determined by fluid uptake which is
modulated by material surface area and the volume of diluent4. We examined material loss
profiles in both domains for disks, blocks or hollow mesh cylinders of PEG:dextran
(D10-50-14 P8-10-40, supplementary Figure 3) all containing 5% fluorescent PEG with
fixed mass. Construct erosion in vivo was calculated from efficiency signals at the region of
interest around the sample (Figure 1a). Erosion was biphasic - comprised of rapid sample
loss presumably through diffusion of non-crosslinked, unreacted PEG and dextran polymeric
chains, followed by more gradual degradation of the crosslinked copolymer network. In
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each case, erosion kinetics in vivo was faster but tracked with the biphasic behavior seen in
vitro (Figure 1b-c). Thin blocks and mesh cylinders with significantly higher surface area
than the disks showed not unexpectedly accelerated erosion in vitro compared with the
erosion in vivo, leading to exponential dependence of the ratio between in vivo and in vitro
erosion with time (Figure 1d, R= 0.99 for both shapes). In contrast, disk erosion was diluent
volume limited and in fixed volume environments in vivo erosion kinetics tracked linearly
with erosion in vitro (Figure 1d, R= 0.98).
Within each hydrogel shape, formulation protocols control erosion profiles as network
formation dictates fluid uptake and depends on the aldehyde:amine ratio. As this ratio is
determined by the relative amounts of PEG and dextran, we examined the effect of PEG
solid content on erosion over a range to the limit of PEG solubility (Fig. 2a). At solid
content less than 10 wt%, constructs lose structural integrity; at higher solid content, better
stability is observed to a threshold value (above 20 wt%). Each data set adhered to the
expected erosion profile and fit a dual exponential decay model. In this model, polymer
mass, M, follows the erosion of two components - free (M1) and crosslinked (M2) material -
each defined by relative proportion of total mass, and a specific erosive rate constant, k, at
each phase M = M1·e(-k1t) + M2·e(−k2t).
The relative measures of the mass components provide an indirect determination of gel
content and degree of crosslinking. Though the ratio of unbound and bound rate constants
(k1/k2) spans an order of magnitude with changes in shape, in a fascinating manner the
relationship between in vivo and in vitro ratios is virtually fixed at 2 (Table S1), providing a
valuable means of assessing erosion in this system. The relative rates of erosion of
crosslinked and free material might allow one to infer in vivo behavior from in vitro
performance, and the very acceleration of in vitro erosion can be used to predict in vivo
erosion. As the number of amine groups increases with PEG content, the unbound
component drops exponentially (Fig. 2c) but overall erosion is still determined by the rate
constant of the bound or crosslinked phase rate (k2) (Fig. 2b). Erosion is limited by
crosslinking and as the number of amine groups available for gel formation rises, erosion
rate drops significantly.
We validated this bi-exponential erosion model and model predictability by prospectively
predicting adhesive erosion profiles for newly synthesized PEG:dextran formulations with
10 or 14% PEG solid contents (formulations specified in Table S2). Erosive behavior was
calculated using values for M1, M2, k1 and k2 extracted from the fits of data in figures 2b-c
and correlated exceptionally with empiric measures of erosion (Fig. 2d, R = 0.99).
The highest benefit of such model would be the ability to predict in vivo erosion kinetics of
newly synthesized materials from in vitro data. This will minimize the number of animals
used and will also serve as a convenient screening platform in vitro. Interestingly, in vivo
erosion (Figure 3a) followed the expected exponential decay and differed with PEG solid
content material erosion as seen with disks in vitro (Figure 2a), establishing a fixed linear
relationship between the in vitro and in vivo erosion versus time for all formulations (Figure
3b). The ratio of erosion rates in both domains correlates with PEG solid content (Figure
3c). This highly sensitive correlation was used to accurately predict in vivo performance
based on in vitro data for all samples in this formulation type (Fig. 3d, R=0.99). Successful
prediction of material erosion demonstrates continuity within the design space and the
potential for strategic adjustment of PEG:dextran composition to meet specific requirements.
PEG:dextrans are dominated by hydrolytic erosive forces, other materials are subject to a
more complex array of forces which often cannot be reproduced and whose impact is
impossible to intuit. Fluorescent tracking enables us to assume that correlation will exist for
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specific environmental condition set and once attained, to inference that these are the
physiologic values. We examined compressed collagen matrices, materials increasingly used
in tissue engineering applications and whose degradation requires fluid imbibition, material
swelling, enzyme penetration and enzymatic bulk degradation (Figure 4). As with hydrogels,
the volume of diluent fluid is critical for erosion, but is increasingly complex in the case of
enzymatic degradation. Diffusion of enzymes into samples and of degradation products out
requires swelling. Hence, surrounding fluid volume determining degree of swelling should
be considered in addition to the classic Michaelis-Menten enzyme kinetics18. Swelling of
our collagen-based material is significantly affected by diluent volume with identical
enzyme concentration (Supplementary Figure 4). While the subcutaneous space of a mouse
has a limited fluid volume, the intraperitoneal cavity is significantly larger, with higher
volume of fluids. Thus, not unexpectedly erosion kinetics in vitro correlated best with in
vivo behavior for specific immersion volumes that varied with implant site (Figure 4). While
in vitro erosion under 25μl diluent highly correlated with in vivo erosion in the subcutaneous
space, linear relationship was obtained for intramuscular and intraperitoneal erosions when
100μl diluent volume was used in vitro. In a most intriguing manner the inferred volumes
and concentration align remarkably with literature reported empirically-obtained values19.
As with the hydrogels, gravimetric analysis of collagen matrices underestimated erosion
early and overestimated erosion late. Sample drying shifted these measures to coincide with
fluorescent assays once again verifying the contamination of signal with swelling. The
gravimetric analysis, however, was further limited as increasingly sensitive scales would
need to be used to track sample weight changes in the regime where fluorescent
quantification remains constantly sensitive (Supplementary Figure 5).
Tracking material erosion is challenging. In vivo performance rarely coincides with erosion
in vitro. Material fate varies with material dimensions, crosslinking, and composition, and
environmental conditions and stresses in vitro that do not necessarily represent the in vivo
state. Pathophysiologic conditions like inflammation cannot be recapitulated in vitro. Two
questions arise–will erosion in vivo follow erosion in vitro even if they occur at different
rates? And, if there is a match between performances in the two domains, can one be
predicted from the other? Indeed, one could use in vitro behavior as a surrogate for erosion
in vivo if such a correlation exits. Here we report that intravital tracking of fluorescent tags
on degradable materials can be used similarly in vivo and in vitro, with a minimum of
samples, sequentially on the same specimen, with significant accuracy and most importantly
in a correlative fashion. In vivo erosion of our selected materials that degrade primarily by
hydrolytic or enzymatic degradation correlates with in vitro erosion, allowing prediction of
the former from the latter. Moreover, erosive materials can be considered like scaffold-
tethered drugs20, where erosion kinetics like release kinetics can be successfully modeled
with a dual exponent system with free and crosslinked polymer elements like free and bound
drug (Fig. 1). Such a system can also now explain the impact of material shape and
dimensions, and material formulation protocols on erosion profiles (Figs. 2–3) facilitating
the design of materials with programmed retention time. Equally important is that such a
system adds great insight into the mechanism of erosion and the physiological conditions
that need to be established in vitro to attain correlation. We can now explain how and why
materials implanted in different target sites, including the subcutaneous, intramuscular and
intraperitoneal spaces, resulted in distinctive erosion profiles. While enzymatic degradation
of materials in vivo is very complex, under the specific set of conditions we have been using,
collagen-based material degradation in vivo could be recapitulated in vitro via variation in
fluid volume with physiological enzyme concentrations (Figure 4a). It is remarkable how the
definition of the in vivo conditions leads to linear correlation between in vivo and in vitro
erosion profiles (Figure 4b-c).
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The ability to detect and predict the time course of in vivo erosion is crucial to the design
and informed regulation and use of increasing number of biomedical devices with erosive
properties. While the data published in this manuscript are material and conditions-specific,
our approach can be adapted to track the erosion of multiple material systems. Moreover,
erosion tracking can be extended beyond the hydrolytic and enzymatic processes examined
here to include complex conjugations. Use of multiple tags can enable examination of
material dynamics, and even the interaction between molecules using advanced fluorescent
methods, such as Fluorescent Resonance Emission Transfer (FRET). The incorporation of
multiple concomitant tags allows independent tracking and correlation of drug release and
material loss from a polymer drug-eluting scaffold,21–23 or the fate of cells and materials
within tissue engineered formulations.24,25 When tagging is not possible, one could entrap
fluorescent molecules e.g., quantum dots, that would serve as surrogate for erosion. It is now
possible to follow the fate of erosive materials in a precise and reproducible manner that can
be used in vivo and in vitro and is amenable to mathematical modeling and prospective
prediction.
Methods
Materials’ selection and characterization are described in the Supplementary Information
Quantifying material erosion using fluorescent signal ex-vivo—Mass loss
kinetics as measured by gravimetric analysis was compared with erosion profiles obtained
by following fluorescent signal loss of labeled materials. To enable erosion detection via
optical imaging, PEG was labeled with fluorescein and collagen with Texas Red.
Fluorescein labeled PEG was synthesized as follows: 2.4g PEG amine was dissolved in 6
mL dichloromethane. Fluorescein-5-carboxyamido hexanoic acid (Invitrogen) was added to
the solution followed by addition of 12 μL triethylamine (Sigma). The mixture was stirred at
room temperature for 48 hours. The solid that remained after solvent evaporation was
dissolved in 100 mL dd water, dialyzed and lyophilized. PEG solution containing 1%
fluorescent PEG was mixed with dextran aldehyde to prepare fluorescent gels. While
materials were submerged in 2ml PBS and shaken at 37°C, media was exchanged daily and
fluorescence intensity in the media was measured at an excitation wavelength of 485nm and
emission wavelength of 538nm. The erosion profile was followed by quantifying the loss of
fluorescent signal with time.
Texas Red® labeled collagen was synthesized by reacting the collagen sponges with Texas
Red®-T succinimidyl ester (5.6 μl per sponge) in 0.2 M bicarbonate buffer (0.320 ml per
sponge), for 2 hours at room temperature. The sponges were rinsed three times in PBS to
remove excess unreactive dye.
Stability of PEG-fluorescein bond—To verify that the fluorescent tag remains attached
to the polymer materials 1ml PEG-F* was placed in a dialysis membrane of cellulose ester
(Spectra/Por Biotech, MWCO=1000, #131096) surrounded by 100ml PBS 1x. Free
fluorescein could then diffuse out and the media was scanned intermittently at excitation and
emission of 485/538nm to quantify the amount of free or detached tag with time.
Quantifying material erosion using fluorescent signal in-vivo—Sterile solutions
passed through 0.2mm filters were used to prepare PEG:dextran constructs in the shapes of
disks, blocks and coated mesh cylinders of the same dimensions as used for in vitro
evaluation. The constructs were implanted subcutaneously into isoflurane-anesthetized nude
albino mice (Charles River Labs) through a 1cm skin incision into the dorsal subcutaneous
space of the mice. The incision and pocket were closed with 7-0 prolene sutures.
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Sterile collagen based samples, 4 mm in diameter were similarly implanted into the
subcutaneous space of a mouse (SC), intraperitoneally (IP) and intramuscularly (IM).
Immediately and at various intervals after surgery, the animals were imaged using the
Xenogen IVIS device using the relevant filter sets. Fluorescence intensity was determined
by calculating the efficiency overlying each construct where the fluorescent intensity is
corrected to eliminate tissue autofluorescence. While fluorescein was used for SC
implantations, Texas Red was used for deeper target sites (IM and IP) to avoid photo
bleaching and light penetration issues. The choice of fluorescent dye is critical, especially
when tracking materials for extended period of times. Optimal dyes are near-IR dyes that do
not undergo photobleaching during the experimental period and do not overlap with tissue
autofluorescence.
Statistical Analyses—Data are presented as mean ± standard deviation unless otherwise
indicated (n = 3 for in vitro swelling and degradation, adhesion and gelation time of PEG-
dextran formulations, n=5 for in vitro erosion characterization of collagen based samples,
n=5 and 10 for in vivo erosion tracking of PEG:dextran and collagen based formulations,
respectively). To take multiple comparisons into account, when comparing swelling and
degradation, statistical comparisons were done using two way ANOVA with replication. A
P-value <0.05 was considered to denote statistical significance.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. In vitro – in vivo correlation of PEG:dextran erosion profiles exists and varies with
material surface area
In vitro and in vivo erosion profiles of PEG-dextran (D10-50-14 P8-10-40) cast in a series of
shapes are depicted by tracking the loss of fluorescence intensity with time. The effect of
material shape on degradation profile was followed in vivo noninvasively in the dorsal
subcutaneous space of the mouse (disk shaped materials are presented) (a), and in vitro (b).
The loss of fluorescent signal with time in vivo was converted to weight loss (c) and
correlated with the in vitro loss (d). An excellent correlation was found between mean
values of in vitro and in vivo erosions of disk ; (R= 0.96), block
; (R= 0.94), and mesh cylinder
; (R= 0.98). Disk erosion in vivo tracked linearly with
erosion in vitro (Figure 1d, R= 0.98). Thin blocks and mesh cylinders with significantly
higher surface area than the disks (116, 190 and 86mm2 respectively) showed accelerated
erosion in vitro compared with the erosion in vivo, leading to exponential dependence of the
ratio between in vivo and in vitro erosion with time (Figure 1d, R= 0.99 for both shapes).
Artzi et al. Page 8














Dual exponential decay model describes PEG:dextran in vitro erosion and enables
prospective prediction of erosion profile of new material formulations. Alteration of PEG
solid content from 10 to 29wt% enables fine-tuning of material erosion kinetics (a). Model
descriptors are presented as a function of PEG solid content. While k1 is constant and k2
decays exponentially (b); M1 and M2 similarly demonstrate reciprocal exponential changes
with PEG solid content (c). The relationships between model descriptors and PEG solid
content (PEGSC) are as follows:
Using the equations describing the relation between model descriptors and PEG solid
content, the erosion profile of new compositions containing 10 and 14wt% PEG were
prospectively predicted (points are empirically accumulated and lines are model predictions)
(d). Constants were extrapolated from the data fits and are inserted in the figures as blue
symbols, while squares represent k1 and M1 and circles represent k2 and M2. Predicted
erosion correlated well with empiric observations (Pearson’s coefficient R= 0.99).
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Figure 3. In vitro– in vivo correlation of PEG:dextran erosion profiles enables prediction of in
vivo erosion kinetics from in vitro data
In vivo erosion of PEG-dextran formulations is depicted and follows the trend of the in vitro
erosion profile, at a faster pace, as demonstrated for compositions with 10, 14, 20 or 29wt%
PEG solid content (a). A linear relationship exists between the ratio of in vivo and in vitro
erosion as a function of time for all PEG solid contents examined (b). The slopes of these
curves linearly correlate with PEG solid content (c). Using this linear relationship, in vivo
erosion profiles of two different formulations were accurately predicted from in vitro data
(R=0.99) (points are empirically accumulated and lines are model predictions) (d).
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Figure 4. In vivo erosion profile is site-dependant and can be used to infer physiologically
relevant in vitro conditions for enzymatic materials
In vitro and in vivo erosion of compressed denatured type II collagen are presented. In vivo
erosion at target sites that differ in enzyme concentration and fluid volume (Subcutaneous
(SC), intraperitoneal (IP) and intramuscular (IM)) is site dependent and fits one exponential
decay model (R=0.44, 0.77, and 0.7 for SC, IP and IM) (a). The in vivo erosion profiles
were used to infer physiologically relevant conditions of diluent volume and enzyme
concentration. While in vitro erosion depends both on enzyme concentration and fluid
volume, a specific set of conditions resulted in an in vitro erosion profile (R=0.71, 0.9, and
0.95 for SC, IP and IM) (b) that linearly correlates with the in vivo erosion (c). The erosion
in both domains fit an exponential decay model. A correlation between the erosion profiles
in vitro and in vivo is achieved when SC implantation is plotted versus in vitro erosion of
material submerged in 25μl of PBS solution containing physiological concentration of
collagenase, and for IM and IP implantations when compared with in vitro erosion using
100μl of PBS containing enzyme solution. Linear correlation between in vitro and in vivo
erosion enables screening of materials in vitro with in vivo prediction capacity.
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